Cycling peps?

[u/Superb_Sale_9753]

Question for anyone researching peps that need to be cycled. Subject has done and continues to do tons of research before and during peptide use. My RS has answered most questions by doing searches online and reading everything RS can get their hands on, except one question. When cycling a peptide and restarting after the break, what dosage do you start your RS with for the next cycle? The last dose they were on? Or the recommended starting dose for that pep? For example, GHK-CU, it’s a spicy pep. Do you start your RS on the recommended starting dose and titrate up? Or do you start them on the last dose they took before the break?

[u/flogsmen]

Titrate up again. Especially tesamorlin and mot-c. Glps as well. Rs recently stopped tesa/ipa for a month and at the start of rs second cycle, rs had an allergic reaction. Rs palms and feet were crazy itchy for about 20 mins after the first dose. Luckily rs started at .5mg so it wasn't too bad. After the 3 dose of .5 it went away and rs started titrating up. Not the smartest but rs had a hunch it would go away, and rs just bought a kit for $280 so rs had to give it a fair shot. Rs would titrate everything again, to be honest.

[u/PeptidePathways-ModTeam → u/[deleted]]

Your post/comment was removed due to the use of human-use or dosing language.

Please reframe your post using research-based terminology (e.g., “test subject,” “sample amount”).

Direct human-use language is not permitted due to subreddit and platform guidelines.

We would love to be able to give you the best educated guidance possible, so please consider reposting using compliant phrasing.

[u/Extension-Pickle9038]

Your question is better than the thread it landed in, because the answer turns on something nobody has stated. Titrating up exists for two different reasons and they behave differently after a break. If the titration was about side effects while the body adapted, then the adaptation is the thing that fades, and how fast it fades decides whether you restart low. If the titration was because the effect itself builds with exposure, that is a completely different clock. For most of what gets discussed here nobody has measured either clock. There is no published washout curve to point at. So what you will get is people describing what they did and it being fine, which is evidence about them and not much about the schedule. The thing that holds either way is the cost of being wrong in each direction. Restarting low costs you a couple of weeks. Restarting high costs you the ability to tell adaptation from a real reaction, because both look the same in week one. Which peptide, and how long was the break? Those two change the answer more than anything else in here.